---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-015846"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2025-09-29T23:59:59+00:00"
generated_at: "2026-05-17T05:23:28.307731+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics appoints Kevin Chen as independent director effective Sept 26, 2025

## Summary
- Kevin Chen, 47, appointed as independent director, effective immediately.
- Chen serves as Chief Economist and CIO of Horizon Financial.
- He holds board seats at CurrenC Group, Australian Oilseeds Investments, Scage Future, Capitan Investment.
- Former board member of Infint Acquisition Corporation; adjunct professor at NYU.
- Chen holds PhD in Finance from University of Lausanne, and BA from Renmin University.

## SEC filing metadata
- accession: 0001493152-25-015846
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2025-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315225015846/0001493152-25-015846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315225015846/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-015846
- JSON: https://secwatch.observer/filing/0001493152-25-015846.json
- Plain text: https://secwatch.observer/filing/0001493152-25-015846.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.